IRLA — IRulya Therapeutics Share News
0.000.00%
Last trade - 00:00- $355.93m
- $383.76m
U.S. RESEARCH ROUNDUP-Cross Country Healthcare, First Solar, ServiceNow
U.S. STOCKS ON THE MOVE-Corning, Stride, Gatos Silver
U.S. STOCKS ON THE MOVE-Corning, F5 Inc, Cortexyme
U.S. STOCKS ON THE MOVE-JinkoSolar, Gatos Silver, Vaccinex Inc
Cortexyme sinks as U.S. FDA puts lead drug trial on hold
Brief: Cortexyme Announces Clinical Hold On Atuzaginstat’S Investigational New Drug Application
Brief: Cortexyme’S Atuzaginstat Slowed Cognitive Decline In Participants With Alzheimer’S Disease And P. Gingivalis Infection In Phase 2/3 Gain Trial Additional Top-Line Data Presented At Ctad 2021
U.S. STOCKS ON THE MOVE-General Motors, JPMorgan, Citigroup, Nurix Therapeutics
U.S. STOCKS ON THE MOVE-Sunnova, Twitter, Hilton, AgriFORCE
U.S. STOCKS ON THE MOVE-Novavax, Enphase Energy, Uber, Cortexyme
U.S. STOCKS ON THE MOVE-Robinhood, Spotify, Cortexyme, JD.com
Cortexyme plunges as Alzheimer's drug fails mid-to-late stage study
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:13 PM
Brief: Cortexyme Reports GAIN Trial Data Demonstrated Relationship Between Reduction Of P. gingivalis Infection & Slowing Of Alzheimer’S Disease Progression
Cortexyme's Alzheimer's treatment fails to meet main goals in study
U.S. RESEARCH ROUNDUP:-Cisco, GXO Logistics, Theravance Biopharma
Brief: Cortexyme Presents New Data Demonstrating Evidence Of P. Gingivalis Infection Of The Central Nervous System In Alzheimer's Disease
Cortexyme expects Alzheimer's drug trial data by mid-Nov; shares hit record high
Brief: Cortexyme - Q2 Loss Per Share $0.74